Ruxolitinib 5mg tablets
NHS hospitals in England used £21,038,261 of indicative cost of Ruxolitinib 5mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 21.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ruxolitinib 5mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ruxolitinib 5mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £1,535,610 |
| Leeds Teaching Hpls Nhs Trust | £908,820 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £880,923 |
| South Tees Hosp Nhs Foundation Trust | £875,058 |
| Southend Univ Hosp Nhs Foundation Trust | £768,978 |
| Manchester University Nhs Ft | £694,391 |
| Royal Devon & Exeter Nhs Foundation Trst | £660,629 |
| Univ Hpl B/Ham Nhs Foundation Trust | £562,326 |
| Barkinghavering & Redbridge Hpls Trst | £498,015 |
| East Kent Hospitals University Nhs Ft | £496,944 |
The primary-care picture
Ruxolitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ruxolitinib medicine page.